Medison Pharma Tech Stack

Global commercialization platform for biotech therapies in emerging markets

Pharmaceutical Manufacturing Petach Tikva 501–1,000 employees Founded 1996 Privately Held

Medison operates a commercialization infrastructure layer for biotech companies scaling outside the U.S., Western Europe, and Japan. The tech stack centers on Veeva (CRM + vault), NetSuite (ERP), and analytical tools (Qlik Sense, IBM Planning Analytics, Jedox, Anaplan) — a classic pharma-compliance-first build. Active hiring across sales, finance, and healthcare roles in 15 countries signals regional expansion, while projects around planning-system modernization (Excel replacement) and complex incentive-compensation cycles reveal operational drag from legacy spreadsheet workflows and multi-brand/multi-market complexity.

Tech Stack 16 technologies

Core StackNetSuite Salesforce Veeva iPad Anaplan Veeva CRM Qlik Sense IBM Planning Analytics Jedox CRM

What Medison Pharma Is Building

◆Challenges

Global pay equity disparities
Process improvement for efficiency
Complexity across brands, markets, functions
Traditional commercialization models
Streamlined financial reporting
Accelerating access to therapies
Managing vendor relationships
Complex incentive compensation calculations
Inefficient crm reporting
High unmet medical needs

▲Active Projects

Process improvement projects for efficiency
Pre-launch and life cycle activities
Commercial assessment for latam partners
Market research activities for bd projects
Scientific programs
Evolution of new planning system to remove excel
Global commercialization platform
Patient access programs
Business improvement workshops
Incentive compensation cycle implementation

Hiring Activity

Accelerating85 roles · 60 in 30d

Department

Sales

Finance

Healthcare

Research

Ops

Product

Marketing

Seniority

Senior

Mid

Manager

Director

Lead

Junior

Notable leadership hires: Business Unit Head, Medical Head, Corporate Development Director, Sales Team Lead, Head of Total Rewards

Company intelligence

Find more companies like Medison Pharma by tech stack, pain points and active projects

Get started free

About Medison Pharma

Medison Pharma is a commercialization-services company that partners with biotech firms to distribute breakthrough therapies — particularly orphan and rare-disease treatments — in markets outside traditional pharma hubs. Founded in 1996 and headquartered in Petach Tikva, Israel, the company operates as a hybrid commercial, medical, and operational entity across diverse geographies. The organization spans 501–1,000 employees with active hiring in 15 countries across sales, finance, healthcare, research, and operations. Current priorities include migrating from Excel-dependent processes to unified planning systems, managing global pay-equity compliance, and scaling patient-access programs alongside life-cycle management for partner pipelines.

HeadquartersPetach Tikva

Company Size501–1,000 employees

Founded1996

Hiring MarketsSouth Korea, Romania, Israel, Poland, Estonia, Hungary, United States, Canada

Frequently Asked Questions

What tech stack does Medison Pharma use?

Medison relies on Veeva (CRM and vault), NetSuite (ERP), Qlik Sense and IBM Planning Analytics for reporting, Salesforce and Veeva CRM for customer relations, and Anaplan and Jedox for financial planning.

What is Medison Pharma working on?

Priority projects include modernizing the planning system to reduce Excel dependency, commercial assessments for LATAM partners, patient access program design, incentive compensation cycle implementation, and market research for business development across their global partner network.

How this profile is built

Medison Pharma's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.